Are you Dr. Gunter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Zymequest Inc, Suite 436h
100 Cummings Center
Beverly, MA 01915Phone+1 978-232-8370- Is this information wrong?
Summary
- Dr. Kurt Gunter, MD is a board certified pathologist in Beverly, Massachusetts. He is currently licensed to practice medicine in Illinois.
Education & Training
National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1987 - 1988
University of MarylandResidency, Pathology-Anatomic and Clinical, 1986 - 1987- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1982 - 1986
University of Kansas School of MedicineResidency, Pathology-Anatomic and Clinical, 1980 - 1982- University of Kansas School of MedicineClass of 1979
Certifications & Licensure
IL State Medical License 2007 - 2026- American Board of Pathology Anatomic Pathology
- American Board of Pathology Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
Clinical Trials
- Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers Start of enrollment: 2004 Mar 01
- Safety Study of ECO Conversion System For Red Blood Cells. Start of enrollment: 2005 Nov 01
- A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin Start of enrollment: 2012 Jan 31
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsCurrent state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizon.Michael Mendicino, Yong Fan, D.L. Griffin, Kurt C. Gunter, Karen Nichols> ;Cytotherapy. 2019 Jul 1
- 7 citationsPart 5: Unproven cell therapies and the commercialization of cell-based products.Robert J. Deans, Kurt C. Gunter, Massimo Dominici, Miguel Forte> ;Cytotherapy. 2016 Jan 1
- 35 citationsPositioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy PerspectiveMassimo Dominici, Karen Nichols, Alok Srivastava, Daniel J. Weiss, Paul Eldridge, Natividad Cuende, Robert J. Deans, John E.J. Rasko, Aaron D. Levine, Leigh Turner, D....> ;Cytotherapy. 2015 Dec 1
- Join now to see all
Press Mentions
Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business UpdatesAugust 15th, 2022- Athenex to Host Key Opinion Leader Webinar on CAR-NKT Approach to CancerNovember 30th, 2021
- Athenex, Texas Children’s Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine Present New Clinical Data on GD2 CAR-NKT Cells in Neuroblastoma at ASGCT Annual MeetingMay 17th, 2021
- Join now to see all
